CHAPTER 266 Biomaterials and Biomechanics of Spinal Arthroplasty
The success associated with replacement of a joint of the appendicular skeleton, such as the hip joint or knee joint, has led to the assumption that joints of the spine may also be amenable to arthroplasty. The functional spinal unit (FSU) is composed of the intervertebral disk and paired facet joints and may be partially augmented (nuclear replacement) or completely replaced (disk arthroplasty, facet joint replacement). Unfortunately, the significant stress placed on the axial skeleton, in combination with the complex biomechanical properties of both the cervical and lumbar spine, such as coupled motion, makes both design of the arthroplasty device and selection of the ideal composite biomaterial a complicated undertaking to say the least. In 1955, Cleveland reported 14 patients in whom he implanted a methyl-acrylic device into the intervertebral space at the time of diskectomy.1 This was followed by Harmon’s use of Vitallium spheres in 13 patients from 1959 to 1961.2 These implants, which were inserted into the lumbar spine through an anterior retroperitoneal approach, led to spontaneous fusion rather than preservation of motion. Another pioneer was Fernstrom, who in 1966 published the outcomes of patients undergoing implantation of a solid stainless steel sphere into the lumbar disk space through a posterior approach at the time of lumbar diskectomy.3 These were important steps that unfortunately met with profound failure. Inadequate surface area resulted in subsidence. Poor design resulted in disk space collapse without restoration of motion. With the advent of more forgiving designs of arthroplasty devices, the challenge has become creation of a device that can withstand hundreds of thousands of wear cycles while allowing ease of insertion and uncomplicated revision.
Historically, anterior cervical decompression with arthrodesis has been a very successful operation for treating both neck pain and cervical spinal cord or root compression syndromes. With the use of interbody graft material and plate fixation, high rates of fusion and high rates of clinical success have been well documented. The surgical goal is solid bony arthrodesis and decompression with a clinical end point of relief of neck pain and neural compression. It has been estimated that failure or pseudarthrosis after attempted anterior cervical fusion may develop in up to 20% of patients.4 Pseudarthrosis may be associated with increasing neck pain, progressive neurological deficit, or the development of spinal deformity. Even in cases of successful fusion, loss of the FSU may transfer biomechanical stress to adjacent levels and presumably lead to more rapid deterioration of affected levels.5,6 Clearly, successful arthroplasty would eliminate the possibility of pseudarthrosis while maintaining neural decompression. This would achieve the ultimate goal of minimizing degeneration of adjacent segments while curing both neck pain and radicular symptoms.
Arthroplasty Biomaterials
Spinal disk arthroplasty designs have clearly been influenced by progress made in the field of hip and knee joint arthroplasty. A number of the designs use a combination of metals and polymers. The polymers or plastics essentially provide some measure of shock absorption for the joint while also providing a low-friction surface for joint articulation. Polymers themselves are not strong enough to tolerate the stress of normal joints and are therefore always supported by a metal base. Articular surfaces may involve a metal-on-metal, metal-on-polymer, ceramic-on-polymer, or ceramic-on-ceramic interface. Two polymers that have been used successfully are polyurethane and the derived ultra-high-molecular-weight polyethylene (UHMWPE). Metallic devices have been constructed from solitary metals such as stainless steel, titanium, and cobalt. Newer devices take advantage of metallic alloys. Alloys are homogeneous mixtures or solid solutions of two or more metals. For example, cobalt-chromium alloy, cobalt-chromium-molybdenum alloy, and titanium-aluminum-vanadium7 have characteristics that make them uniquely suited for use in arthroplasty. The alloys seem to wear more slowly than polymers and may resist corrosion better than single-metal implants.
Use of a metallic alloy such as cobalt-chromium-molybdenum to minimize the effects of oxidative corrosion unfortunately does not eliminate the concern for wear of the articular surface. Any articulating surface will generate debris secondary to friction. The greater the physiologic load on the device, as well as the greater the ROM, the greater the generation of wear debris. In particular, Hellier and coauthors published the results of determining the absolute and relative wear volume rates of various metal alloys through simulation of an intervertebral disk prosthesis.8 It was found that among all the available alloys, a cobalt-chromium-molybdenum (CoCrMo) alloy generated the least amount of wear debris. It had an average wear volume rate of 0.093 mm3 per million cycles from an arthroplasty device, whereas a titanium alloy containing 6% aluminum and 4% vanadium (Ti6Al4V) had an average wear volume rate of 2.9 mm3 per million cycles. Schmiedberg and colleagues in 1994 used scanning electron microscopy to further define the size and shape of the wear debris fragments generated from an arthroplasty articular surface.7 The fragments from a titanium-aluminum-vanadium surface are extremely rough and irregularly shaped. The size of the fragments ranges from less than 1.0 µm to greater than 30 µm. Fragments from the cobalt-chromium-molybdenum alloy have an irregular polyhedral shape when the alloy was formed from a forged process, but the fragments have a spherical shape ranging between 5.0 and 30 µm when the alloy was formed from a hot isostatically pressed process. Catelas and associates published the results of their study investigating wear debris in metal-on-metal total hip arthroplasty devices.9 The study, published in 2003, demonstrated a significant number of wear debris particles composed predominantly of chromium oxide particles, with estimated loss rates as high as 100 mm3/yr for hip arthroplasty.